Join | Renew | Donate
The GHSN quarterly newsletter features the latest news on the GHSN, upcoming global health meetings, health security news and much more...
Download Q2 now.
Join the conversation on global health security and take part in the online policy forums. Meet and network with other members from around the world.
Start a Conversation now...
The GHSN blog is regularly updated with latest news articles on health security. As a member we encourage you to share any news articles you find informative so that we can share research around the world.
The British government has announced it will start operating 24-hour COVID-19 vaccine centres to help reach its target of inoculating at least 14 million people by February the 15th.
Two gorillas have tested positive for COVID-19 while a third appears symptomatic at San Diego Zoo in the United States.
Watch Sky News
Chief medical officer Paul Kelly has tried to calm worries about the efficacy of the AstraZeneca vaccine, amid concerns the government has put all its eggs in one basket. SBS Reports
The WHO has warned it will not be possible to produce and administer enough coronavirus vaccine doses this year to achieve herd immunity. SBS reports
A team of 10 experts, led by the World Health Organization, will seek to determine the origin of the deadly COVID-19 virus and how it spread to the human population. SBS Reports
Los Angeles is now at the heart of the country's COVID-19 pandemic, with hospitals overflowing and many essential workers among the patients. Read more
The record 1,325 deaths eclipsed the previous worst from April during the height of the first wave last year, and brings the total number of fatalities to 79,833. SBS Reports
Sweden, known for its soft-touch response to the coronavirus pandemic, is now battling a severe second wave of the disease. Read more
The Korea Disease Control and Prevention Agency (KDCA) on Monday reported 718 new coronavirus cases, down from the record daily increase of 1,030 a day earlier. SBS Reports
The University of Queensland (UQ) and biotechnology company CSL on Friday morning announced they won't progress trials of their COVID-19 vaccine candidate into the second and third phases after some participants returned false-positive results for HIV. SBS Reports